This does not mean one procedure, but typically includes CQA roles and responsibilities, vendor ID, selection, and management, training, internal audits, external audits (for CROs/service providers, investigator site audits, phase 1 unit audits, CSR audits), internal oversight procedures, depending on the internal activities that go on in your company, training, Quality Agreements, protocol deviations, review and approval of clinical documents, request for shipment of clinical supplies, etc.
There are numerous activities that must have procedures depending on whether your company is virtual or if you do these activities in house and that will impact sops in Regulatory (listing on clintrials.gov, and release of initial drug shipments to clinical sites) and clinical (review and approval of protocols and other clinical documents that should have CQA involvement, etc.) I would need more information on how your company operates to give you a thorough answer. You are welcome to contact me directly if you need more information
dmurgai@gxpqsllc.com .
------------------------------
Dalal Murgai
Chief Operating Officer
GXP Quality Systems, LLC.
The Woodlands TX
United States
------------------------------
Original Message:
Sent: 16-Apr-2019 11:20
From: Anonymous Member
Subject: Clinical Quality Assurance Procedures - Medical Device Trials
This message was posted by a user wishing to remain anonymous
Hi everyone,
According to ISO 14155, the sponsor is responsible for establishing clinical quality assurance procedures. Can somebody provide any guidance on what elements should be included in this clinical quality assurance procedure?
Thanks!